J Med Virol . Recurrent Covid-19 Pneumonia in the course of chemotherapy: consequence of a weakened immune system?

[tetano]

J Med Virol


. 2020 Nov 28.
doi: 10.1002/jmv.26701. Online ahead of print.
Recurrent Covid-19 Pneumonia in the course of chemotherapy: consequence of a weakened immune system?


Michelangelo Luciani ¹ , Enrico Bentivegna ¹ , Valerio Spuntarelli ² , Piera Amoriello Lamberti ¹ , Giulio Cacioli ³ , Flavia Del Porto ¹ , Giorgio Sesti ¹ , Paolo Martelletti ² , Luciano De Biase ^{2 4}



Affiliations

• PMID: 33247596
• DOI: 10.1002/jmv.26701

Abstract

One of the objectives that the scientific community is setting itself is to understand whether acquired immunity and the presence of antibodies against acute coronavirus 2 (SARS-CoV-2) antibodies protect against reinfection. Although there are many published papers describing how the re-positivization of nasopharyngeal swab polymerase chain reaction real time (RT-PCR) test and clinical healing of the subject can be justified by numerous reasons and random situations. Our aim is to highlight how there are certain populations more susceptible to re-infection than others. This article is protected by copyright. All rights reserved.

Keywords: Immunodulators < Disease control; Immunomodulation < Immune responses; Reinfection < Immune responses; SARS coronavirus < Virus classification.